Valeant Pharma (VRX) Comments on Philidor Criminal Complaint; Says Co., Former CEO/CFO Not Yet Charged
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Additional Charges Against Valeant Pharma (VRX) or Former Execs Cannot Be Ruled Out - Wells Fargo's Maris
November 17, 2016 1:46 PM ESTWells Fargo analyst David Maris weighed in on Valeant Pharma (NYSE: VRX) after today's DOJ press conference. Maris said based on the comments additional charges against Valeant or former Valeant executives cannot be ruled out,
Maris commented, "Earlier in the day, a Valeant... More
Valeant Pharma (VRX) Off Lows as Charges Relate to Employee Fraud Versus Company Fraud
November 17, 2016 11:45 AM ESTValeant Pharma (NYSE: VRX) is bouncing off morning lows as the charges against former exec Gary Tanner and CEO the Philidor Andrew Davenport appear more related to individual fraud versus company fraud. Shares of VRX are down 2% after trading down 7%... More
Valeant (VRX) puts active on U.S. Attorney charges against ex-Valeant executive, ex-Philidor CEO
November 17, 2016 9:53 AM ESTValeant Pharma (NYSE: VRX) November 16.50 and 17 puts are active on total put volume of 16K contracts (7K calls) after U.S. Attorney announce charges against ex-Valeant executive, ex-Philidor CEO. November put option implied volatility is at 155, December is at 84; compared to its 52-week range of 53 to 174.
... MoreEx-Valeant executive, ex-pharmacy CEO charged for fraud scheme
November 17, 2016 9:46 AM ESTBy Nate Raymond
NEW YORK (Reuters) - A former Valeant Pharmaceuticals International Inc (NYSE: VRX) executive and the former CEO of mail order pharmacy Philidor Rx Services were arrested on Thursday on charges that they engaged in a multimillion-dollar fraud and kickback scheme.
Federal prosecutors in Manhattan accused Gary Tanner, a ex-senior Valeant director, of secretly working with former Philidor Chief Executive Officer Andrew Davenport to promote the specialty pharmacy's business within the Canadian drugmaker.
The scheme culminated in Valeant agreeing to pay $100 million for the right to buy now-defunct Philidor,... More
New York DOJ Attorney Announces Charges Against Two Former Valeant Pharma (VRX) Execs
November 17, 2016 9:38 AM ESTNew York Southern District DOJ Attorney Preet Bharara announces charges against Gary Tanner, a former executive at Valeant Pharmaceuticals International, Inc., (NYSE: VRX) and Andrew Davenport, the former Chief Executive Officer of Philidor Rx Services LLC, for engaging in a multi-million dollar fraud and... More
Two Valeant (VRX) -Linked Executives Said to be Arrested Thursday - Bloomberg
November 17, 2016 9:36 AM EST(Updated)
Two executives linked to Valeant Pharma (NYSE: VRX) were said to be arrested Thursday, according to Bloomberg. Those arrested included Gary Tanner, former executive at Valeant, and Andrew Davenport, former CEO of Philidor Rx.
... More
